Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration

Clinical Science

Volumn 129, Issue 8, 2015, Pages 741-756

  Hulse, Richard P ^a,b   Beazley Long, Nicholas ^a,b   Ved, Nikita ^b,c   Bestall, Samuel M ^b   Riaz, Hamza ^a   Singhal, Priya ^a   Hofer, Kurt Ballmer ^d   Harper, Steve J ^a   Bates, David O ^a,b   Donaldson, Lucy F ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

Diabetic neuropathy; Rat; Streptozotocin; Transient receptor potential ankyrin 1 (TRPA1); Vascular endothelial growth factor (VEGF) A165b

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINOCICEPTIVE AGENT; CALCIUM; CASPASE 3; EVANS BLUE; NEUROPROTECTIVE AGENT; RECOMBINANT VASCULOTROPIN; STREPTOZOCIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR A 165B; VASCULOTROPIN A; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRPA1 PROTEIN, RAT;

ADULT; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ANTINOCICEPTION; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; EMBRYO; EXPERIMENTAL SCIATIC NERVE INJURY; EXTRAVASATION; FEMALE; HIND PAW; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; NEUROPATHIC PAIN; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SAPHENOUS NERVE; SENSORY NERVE CELL; SENSORY NEUROPATHY; SPINAL GANGLION; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; ANIMAL; CELL LINE; COMPLICATION; DIABETIC NEUROPATHIES; DIAGNOSTIC USE; DRUG EFFECTS; DRUG SCREENING; EXPERIMENTAL DIABETES MELLITUS; MALE; NERVE DEGENERATION; NEURALGIA; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DRUG EVALUATION, PRECLINICAL; EVANS BLUE; FEMALE; GANGLIA, SPINAL; HYPERGLYCEMIA; MALE; NERVE DEGENERATION; NEURALGIA; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SENSORY RECEPTOR CELLS; TRPC CATION CHANNELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84942896923     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150124     Document Type: Article

References (59)

1. Obrosova, I.G. (2009) Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 6, 638-647
2. Tomlinson, D.R. and Gardiner, N.J. (2008) Diabetic neuropathies: components of etiology. J. Peripher. Nerv. Syst. 13, 112-121
3. Chen, X. and Levine, J.D. (2003) Altered temporal pattern of mechanically evoked C-fiber activity in a model of diabetic neuropathy in the rat. Neuroscience 121, 1007-1015
4. Christianson, J.A., Ryals, J.M., Johnson, M.S., Dobrowsky, R.T. and Wright, D.E. (2007) Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience 145, 303-313
5. Tomlinson, D.R. and Gardiner, N.J. (2008) Glucose neurotoxicity. Nat. Rev. Neurosci. 9, 36-45
6. Duran-Jimenez, B., Dobler, D., Moffatt, S., Rabbani, N., Streuli, C.H., Thornalley, P.J., Tomlinson, D.R. and Gardiner, N.J. (2009) Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes 58, 2893-2903
7. Calcutt, N.A., Jolivalt, C.G. and Fernyhough, P. (2008) Growth factors as therapeutics for diabetic neuropathy. Curr. Drug Targets 9, 47-59
8. Wei, H., Hamalainen, M.M., Saarnilehto, M., Koivisto, A. and Pertovaara, A. (2009) Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals. Anesthesiology 111, 147-154
9. Koivisto, A., Hukkanen, M., Saarnilehto, M., Chapman, H., Kuokkanen, K., Wei, H., Viisanen, H., Akerman, K.E., Lindstedt, K. and Pertovaara, A. (2012) Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy. Pharmacol. Res. 65, 149-158
10. Kamiya, H., Murakawa, Y., Zhang, W. and Sima, A.A. (2005) Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes. Diabetes Metab. Res. Rev. 21, 448-458
11. Pawson, E.J., Duran-Jimenez, B., Surosky, R., Brooke, H.E., Spratt, S.K., Tomlinson, D.R. and Gardiner, N.J. (2010) Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes. Diabetes 59, 509-518
12. Verheyen, A., Peeraer, E., Lambrechts, D., Poesen, K., Carmeliet, P., Shibuya, M., Pintelon, I., Timmermans, J.P., Nuydens, R. and Meert, T. (2013) Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies. Neurosci 244, 77-89
13. Beazley-Long, N., Hua, J., Jehle, T., Hulse, R.P., Dersch, R., Lehrling, C., Bevan, H., Qiu, Y., Lagreze, W.A., Wynick, D. et al. (2013) VEGF-A165b Is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro. Am. J. Pathol 183, 918-929
14. Sondell, M., Lundborg, G. and Kanje, M. (1999) Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19, 5731-5740
15. Lin, J., Li, G., Den, X., Xu, C., Liu, S., Gao, Y., Liu, H., Zhang, J., Li, X. and Liang, S. (2010) VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X(2/3) receptor of primary sensory neurons. Brain Res. Bull. 83, 284-291
16. Hulse, R.P., Beazley-Long, N., Hua, J., Kennedy, H., Prager, J., Bevan, H., Qiu, Y., Fernandes, E.S., Gammons, M.V., Ballmer-Hofer, K. et al. (2014) Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia. Neurobiol. Dis. 71, 245-259
17. Kawamura, H., Li, X., Goishi, K., van Meeteren, L.A., Jakobsson, L., Cebe-Suarez, S., Shimizu, A., Edholm, D., Ballmer-Hofer, K., Kjellen, L. et al. (2008) Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood 112, 3638-3649
18. Woolard, J., Wang, W.Y., Bevan, H.S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R.O., Cui, T.G., Sugiono, M., Waine, E. and Perrin, R. (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64, 7822-7835
19. Quattrini, C., Jeziorska, M., Boulton, A.J. and Malik, R.A. (2008) Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care 31, 140-145
20. Calcutt, N.A. (2004) Modeling diabetic sensory neuropathy in rats. Pain Research: Methods and Protocols (Luo, Z.D., ed.), pp. 55-65, Humana Press, Totowa
21. Oltean, S., Qiu, Y., Ferguson, J.K., Stevens, M., Neal, C., Russell, A., Kaura, A., Arkill, K.P., Harris, K., Symonds, C. et al. (2014) Vascular endothelial growth factor-A165b is protective and restores endothelial glycocalyx in diabetic nephropathy. J. Am. Soc. Nephrol., doi:10.1681/ASN.2014040350
22. Rennel, E.S., Hamdollah-Zadeh, M.A., Wheatley, E.R., Magnussen, A., Schuler, Y., Kelly, S.P., Finucane, C., Ellison, D., Cebe-Suarez, S., Ballmer-Hofer, K. et al. (2008) Recombinant human VEGF165b protein is an effective anti-cancer agent in mice. Eur. J. Cancer 44, 1883-1894
23. Drake, R.A., Hulse, R.P., Lumb, B.M. and Donaldson, L.F. (2014) The degree of acute descending control of spinal nociception in an area of primary hyperalgesia is dependent on the peripheral domain of afferent input. J. Physiol. 592, 3611-3624
24. Hargreaves, K., Dubner, R., Brown, F., Flores, C. and Joris, J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-88
25. Hamilton, R.T., Bhattacharya, A., Walsh, M.E., Shi, Y., Wei, R., Zhang, Y., Rodriguez, K.A., Buffenstein, R., Chaudhuri, A.R. and Van Remmen, H. (2013) Elevated protein carbonylation, and misfolding in sciatic nerve from db/db and Sod1(-/-) mice: plausible link between oxidative stress and demyelination. PLoS One 8, e65725
26. Xu, Q., Qaum, T. and Adamis, A.P. (2001) Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest. Ophthalmol. Vis. Sci. 42, 789-794
27. Russell, J.W., Golovoy, D., Vincent, A.M., Mahendru, P., Olzmann, J.A., Mentzer, A. and Feldman, E.L. (2002) High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J. 16, 1738-1748
28. Chen, W., Mi, R., Haughey, N., Oz, M. and Hoke, A. (2007) Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal line. J. Peripher. Nerv. Syst. 12, 121-130
29. Arimura, A., Deguchi, T., Sugimoto, K., Uto, T., Nakamura, T., Arimura, Y., Arimura, K., Yagihashi, S., Nishio, Y. and Takashima, H. (2013) Intraepidermal nerve fiber density and nerve conduction study parameters correlate with clinical staging of diabetic polyneuropathy. Diabetes Res. Clin. Pract. 99, 24-29
30. Casanova-Molla, J., Morales, M., Planas-Rigol, E., Bosch, A., Calvo, M., Grau-Junyent, J.M. and Valls-Sole, J. (2012) Epidermal Langerhans cells in small fiber neuropathies. Pain 153, 982-989
31. Ohta, T., Imagawa, T. and Ito, S. (2007) Novel agonistic action of mustard oil on recombinant and endogenous porcine transient receptor potential V1 (pTRPV1) channels. Biochem. Pharmacol. 73, 1646-1656
32. Galloway, C. and Chattopadhyay, M. (2013) Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in type 2 diabetes. Cytokine 63, 1-5
33. Ragavendran, J.V., Laferriere, A., Xiao, W.H., Bennett, G.J., Padi, S.S., Zhang, J. and Coderre, T.J. (2013) Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain. J. Pain 14, 66-78
34. Habib, A.A. and Brannagan, III, T.H (2010) Therapeutic strategies for diabetic neuropathy. Curr. Neurol. Neurosci. Rep. 10, 92-100
35. Hamzeh, H., Gaudillere, A., Sabido, O., Tchou, I., Lambert, C., Schmitt, D., Genin, C. and Misery, L. (2000) Expression of PGP9.5 on Langerhans' cells and their precursors. Acta Derm. Venereol. 80, 14-16
36. Simard, B., Gabra, B.H. and Sirois, P. (2002) Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice. Can. J. Physiol. Pharmacol. 80, 1203-1207
37. Zochodne, D.W. (1996) Is early diabetic neuropathy a disorder of the dorsal root ganglion? A hypothesis and critique of some current ideas on the etiology of diabetic neuropathy. J. Peripher. Nerv. Syst. 1, 119-130
38. Ibrahim, S., Harris, N.D., Radatz, M., Selmi, F., Rajbhandari, S., Brady, L., Jakubowski, J. and Ward, J.D. (1999) A new minimally invasive technique to show nerve ischaemia in diabetic neuropathy. Diabetologia 42, 737-742
39. Costa, P.Z. and Soares, R. (2013) Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox. Life Sci. 92, 1037-1045
40. Deguchi, T., Hashiguchi, T., Horinouchi, S., Uto, T., Oku, H., Kimura, K., Makisumi, K. and Arimura, K. (2009) Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage. Diabet. Med. 26, 247-252
41. Motawi, T.K., Rizk, S.M., Ibrahim, I.A. and El-Emady, Y.F. (2014) Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy. Cell Biochem. Funct. 32, 155-163
42. Chattopadhyay, M., Krisky, D., Wolfe, D., Glorioso, J.C., Mata, M. and Fink, D.J. (2005) HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther. 12, 1377-1384
43. Murakami, T., Arai, M., Sunada, Y. and Nakamura, A. (2006) VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice. J. Gene Med. 8, 773-781
44. Price, S.A., Dent, C., Duran-Jimenez, B., Liang, Y., Zhang, L., Rebar, E.J., Case, C.C., Gregory, P.D., Martin, T.J., Spratt, S.K. and Tomlinson, D.R. (2006) Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy. Diabetes 55, 1847-1854
45. Schratzberger, P., Walter, D.H., Rittig, K., Bahlmann, F.H., Pola, R., Curry, C., Silver, M., Krainin, J.G., Weinberg, D.H., Ropper, A.H. and Isner, J.M. (2001) Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest. 107, 1083-1092
46. Ropper, A.H., Gorson, K.C., Gooch, C.L., Weinberg, D.H., Pieczek, A., Ware, J.H., Kershen, J., Rogers, A., Simovic, D., Schratzberger, P. et al. (2009) Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann. Neurol. 65, 386-393
47. Simovic, D., Isner, J.M., Ropper, A.H., Pieczek, A. and Weinberg, D.H. (2001) Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch. Neurol. 58, 761-768
48. Eisenstein, M. (2012) Sangamo's lead zinc-finger therapy flops in diabetic neuropathy. Nat. Biotechnol. 30, 121-123
49. Simon-Yarza, T., Formiga, F.R., Tamayo, E., Pelacho, B., Prosper, F. and Blanco-Prieto, M.J. (2012) Vascular endothelial growth factor-delivery systems for cardiac repair: an overview. Theranostics 2, 541-552
50. Materazzi, S., Fusi, C., Benemei, S., Pedretti, P., Patacchini, R., Nilius, B., Prenen, J., Creminon, C., Geppetti, P. and Nassini, R. (2012) TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism. Pflugers Arch. 463, 561-569
51. McNamara, C.R., Mandel-Brehm, J., Bautista, D.M., Siemens, J., Deranian, K.L., Zhao, M., Hayward, N.J., Chong, J.A., Julius, D., Moran, M.M. and Fanger, C.M. (2007) TRPA1 mediates formalin-induced pain. Proc. Natl. Acad. Sci. U.S.A. 104, 13525-13530
52. Ferrari, L.F., Bogen, O. and Levine, J.D. (2010) Nociceptor subpopulations involved in hyperalgesic priming. Neuroscience 165, 896-901
53. Meseguer, V., Alpizar, Y.A., Luis, E., Tajada, S., Denlinger, B., Fajardo, O., Manenschijn, J.A., Fernandez-Pena, C., Talavera, A., Kichko, T. et al. (2014) TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins. Nat. Commun. 5, 3125
54. Bates, D.O., Hillman, N.J., Williams, B., Neal, C.R. and Pocock, T.M. (2002) Regulation of microvascular permeability by vascular endothelial growth factors. J. Anat. 200, 581-597
55. Tsantoulas, C., Zhu, L., Shaifta, Y., Grist, J., Ward, J.P., Raouf, R., Michael, G.J. and McMahon, S.B. (2012) Sensory neuron downregulation of the Kv9.1 potassium channel subunit mediates neuropathic pain following nerve injury. J. Neurosci. 32, 17502-17513
56. Dunham, J.P., Kelly, S. and Donaldson, L.F. (2008) Inflammation reduces mechanical thresholds in a population of transient receptor potential channel A1-expressing nociceptors in the rat. Eur. J. Neurosci. 27, 3151-3160
57. Barriere, D.A., Rieusset, J., Chanteranne, D., Busserolles, J., Chauvin, M.A., Chapuis, L., Salles, J., Dubray, C. and Morio, B. (2012) Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization. Pain 153, 553-561
58. Eberhardt, M.J., Filipovic, M.R., Leffler, A., de la Roche, J., Kistner, K., Fischer, M.J., Fleming, T., Zimmermann, K., Ivanovic-Burmazovic, I., Nawroth, P.P. et al. (2012) Methylglyoxal activates nociceptors through transient receptor potential channel A1 (TRPA1): a possible mechanism of metabolic neuropathies. J. Biol. Chem. 287, 28291-28306
59. Nowak, D.G., Woolard, J., Amin, E.M., Konopatskaya, O., Saleem, M.A., Churchill, A.J., Ladomery, M.R., Harper, S.J. and Bates, D.O. (2008) Expression of pro-and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J. Cell Sci. 121, 3487-3495